Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 20, 2025General medicine and Clinical PracticeOpen Access

Hematologic and Immunologic Crossroads: HIV in Sickle Cell Disease Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

EOEmmanuel Ifeanyi Obeagu

Discussion

Loading...

Member takes

Overview

This review explores how HIV worsens outcomes in sickle cell disease patients, highlighting implications for hematologic and immunologic systems.

Key Points

  • HIV exacerbates sickle cell disease complications, increasing infections and vaso-occlusive crises.
  • Immunosuppression from HIV leads to an increased risk of organ damage and infections in SCD patients.
  • Interactions between HIV medications and SCD treatments require careful management to optimize patient care.
  • The combined effects of chronic inflammation in SCD and immune dysfunction from HIV worsen disease severity.

Cite This Study

Emmanuel Ifeanyi Obeagu (2025) studied this question.

synapsesocial.com/papers/68d4390d713b0b5dfea78c55https://doi.org/10.31579/2639-4162/261
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Thrombosis risk in sickle cell disease with HIV co-infection: unraveling the complex interactions and clinical implications – a narrative review2025 · 1 citations
  2. 2Antiretroviral Therapy and Sickle Cell Disease: Balancing Efficacy and Toxicity2025
  3. 3HIV-1–Infected SCD patients exhibit milder sickle cell disease and suppressed antiviral innate immune responses2025
  4. 4A perfect storm: the deadly intersection of sickle cell disease and COVID-192025
  5. 5Treatment disparities in sickle cell disease among patients with asymptomatic HIV2025